Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group
Sponsor: Saint-Louis Hospital, Paris, France
Summary
Crohn's disease (CD), a chronic inflammatory process in intestinal segments leads to tissue damage. More than two thirds of CD patients need intestinal resection. Symptomatic clinical recurrence occurs in 60% by 10 years. The principal factors affecting postoperative recurrence are active smoking, penetrating disease, perianal lesions history, prior intestinal resection, small bowel resection extent, and prophylaxis treatment absence. Ileocolonoscopy within one year of surgery can predict clinical recurrence risk. Different therapies are proposed after surgery, to prevent post-operative recurrence : Thiopurines, 6-mercaptopurine (positive for clinical and endoscopic postoperative recurrence prevention), Anti-tumour necrosis factor therapy (anti-TNF), the most effective therapy. Intestinal microbiota acts as a central factor in the CD pathogenesis, and fecal stream role is clearly shown. Various changes in luminal flora with a possible link to local inflammation was also demonstrated. Bacteria associated with postoperative recurrence could be more pathogenic as adherent invasive E coli (AIEC), which could be a pathogen in CD through several mechanisms including increased mucosal colonization, adherence, replication and induction of TNF secretion. Alternatively, postoperative CD recurrence could be linked to a protective commensal species lack, such as Faecalibacterium prausnitzii. Microscopic inflammation occurs as early as 8 days after anastomosis in the neoterminal ileum mucosa. IL6, IL10 and TGFb levels, measured in neoterminal ileum early after surgery are associated with different rates of postoperative recurrence. It suggests cytokines implication in postoperative recurrence. T cells are major players in the intestinal immune response. The presence at time of surgery and persistence of disease inducing T cell clonal expansions could play an important role in post-operative recurrence. The main objective is to define a classification of ileal Crohn's Disease based on data integration on a large cohort of patients.
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
575
Start Date
2009-12-10
Completion Date
2026-12
Last Updated
2024-04-18
Healthy Volunteers
No
Conditions
Interventions
bio-banking collection
blood samples, biopsies, and surgical specimen collected in addition to usual practice
Locations (17)
SART Tilman Hospital
Liège, Belgium
Amiens Hospital
Amiens, France
Haut-levêque Hospital
Bordeaux, France
Clermont-Ferrand Hospital
Clermont-Ferrand, France
Beaujon Hospital
Clichy, France
Henri Mondor Hospital
Créteil, France
Kremlin-Bicêtre Hospital
Le Kremlin-Bicêtre, France
Lille Hospital
Lille, France
Hôpital Nord, CHU Marseille
Marseille, France
Montpellier Hospital
Montpellier, France
Brabois Hospital
Nancy, France
Nantes Hospital
Nantes, France
Archet 2 Hospital
Nice, France
Saint Louis Hospital
Paris, France
Saint Antoine Hospital
Paris, France
South Lyon Hospital
Pierre-Bénite, France
Strasbourg Hospital
Strasbourg, France